TICKERNERD
Menu
UNHUNHHealthcare · Healthcare Plans

UNH Stock Forecast: UnitedHealth Group, Inc. Price Predictions for 2026-2027

Last close, 4 Nov 2026
$409
+1.22% on the day

The 26 Wall Street analysts covering UnitedHealth Group, Inc. hold a median 12-month price target of $490 — +19.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 81 of 100 as at 3 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$367.4B
Ticker Nerd rank
81/ 100
Median analyst target
$490
Analysts covering
26
Revenue$112.0B+0.4% y/y
Operating income$8.0B
Net income$5.7B
Free cash flow$10.3B
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+0.6%
1M
+10.1%
YTD
+26.4%
1Y
+27.0%
From 52W high
−5.6%
From 52W low
+59.9%
$256
$434
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

UNH stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores UnitedHealth Group, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 3 Nov 2026
81/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Revisions
97
Volatility
94
Issuance
91
Value
83
Momentum
63
Accruals
52
Growth
49
Quality
46
Size
1

Revisions (97): Analysts have, on balance, been raising their forecasts.

Quality (46): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Size (1): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

UNH stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on UNH, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$200$300$400$500$600Jan 26Apr 26Jul 26Oct 26UNHHigh $531Median $490Low $380

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says26 analysts
21 Buy5 Hold0 Sell
Low $380Median $490High $531

The green dot is the last close — the median target sits +19.7% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 6 moved their price target up and 5 moved it down.

DateFirmActionRatingTarget
27 Oct 2026Morgan StanleyMaintainsOverweight$529 → $531
27 Oct 2026Wells FargoMaintainsOverweight$526 → $487
22 Oct 2026MizuhoMaintainsOutperform$493 → $500
20 Oct 2026RBC CapitalMaintainsOutperform$478 → $498
16 Oct 2026BernsteinMaintainsOutperform$512 → $500
16 Oct 2026BernsteinMaintainsOutperform—
16 Oct 2026JP MorganMaintainsOverweight$516 → $524
16 Oct 2026JP MorganMaintainsOverweight—
15 Oct 2026TD CowenReiteratesHold—
15 Oct 2026TD CowenReiteratesHold$402
14 Oct 2026BairdMaintainsNeutral$453 → $427
14 Oct 2026BairdMaintainsNeutral—
14 Oct 2026BarclaysMaintainsOverweight$441 → $440
14 Oct 2026BarclaysMaintainsOverweight—
14 Oct 2026Piper SandlerMaintainsOverweight—
14 Oct 2026Piper SandlerMaintainsOverweight$502 → $504
9 Oct 2026TD CowenMaintainsHold$430 → $402
9 Oct 2026TD CowenMaintainsHold—
21 July 2026JP MorganMaintainsOverweight$466 → $516
21 July 2026JP MorganMaintainsOverweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

UNH appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.

Free. Unsubscribe any time.

The AI build-out map
PDF

  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and serversIn full

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

UNH vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 4 Nov 2026, UnitedHealth Group, Inc. returned +27.0% against +12.9% for the S&P 500, dividends included.

UNH vs S&P 500, last 12 monthsTotal return, rebased to 100
8090100110120130140Jan 26Apr 26Jul 26Oct 26UNHS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

UNH analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
+3.9%
Analysts raising
2
Analysts cutting
0
Fundamentals

UnitedHealth Group, Inc. (UNH) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
23.4×

Cheaper than 33% of US stocks

Price / sales
0.8×

Cheaper than 73% of US stocks

Price / book
3.5×

Cheaper than 27% of US stocks

EV / EBITDA
14.3×

Cheaper than 25% of US stocks

Growth & margins
Revenue growth (YoY)
−0.4%

Higher than 27% of US stocks

Earnings growth (YoY)
75.0%

Higher than 80% of US stocks

Gross margin
20.8%

Higher than 22% of US stocks

Operating margin
5.8%

Higher than 56% of US stocks

Net margin
3.5%

Higher than 56% of US stocks

Returns & dividend
Return on equity
15.8%

Higher than 75% of US stocks

Return on assets
5.2%

Higher than 78% of US stocks

Dividend yield
2.3%

Higher than 82% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

UnitedHealth Group, Inc. (UNH) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • UnitedHealth Group, Inc. has a market value of $367.4B and an enterprise value of $412.0B.

  • Revenue in the twelve months to 30 June 2026: $450.1B. The latest quarter shrank 0.4% year on year.

  • Net income over the same four quarters: $14.9B, a 3.3% net margin.

  • Diluted earnings per share, trailing twelve months: $15.54.

  • Free cash flow in the twelve months to 30 June 2026: $23.6B.

  • UnitedHealth Group, Inc. spent $1.6B on share buybacks and $8.1B on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 905.0M.

  • Trailing P/E: 23.4×; forward P/E: 17.6× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 2.27%, paying out 52% of earnings.

  • UnitedHealth Group, Inc. employs 390,000 people — $1.2M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 4 Nov 2026

Data provided by Twelve Data

Peers

UNH vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealthcare Plans
CompanyMarket capTKN rank
UNHUnitedHealth Group, Inc.$367.4B81
CVSCVS Health Corp.$116.0B82
ELVElevance Health, Inc.$92.0B77
CIThe Cigna Group$78.1B77
HUMHumana, Inc.$50.3B52
CNCCentene Corp.$33.2B93
MRKMerck & Co., Inc.*$359.1B85

* Nearest Healthcare names by size — few healthcare plans companies of this scale trade in the US universe.

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own UnitedHealth Group, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest UNH news & analysis

November Dogs Of The Dow: No Buys, Yet 5 Are Worth Watching

Seeking Alpha · 4 Nov 2026neutral

The article says no top-ten Dow Dogs currently meet the ideal dividend-to-price ratio, while 21 of 30 are described as safer because robust free cash flow supports payouts. It notes elevated risk and volatility despite analyst targets projecting potential gains through November 2027.

Why it matters — The article offers broader context on dividend valuations and payout safety among Dow components, but the excerpt does not make a UnitedHealth-specific assessment.

UnitedHealth Stock Climbs: What's Going On?

Benzinga · 4 Nov 2026positive

UnitedHealth shares rose Wednesday as health care stocks climbed and the company announced a dividend payout.

Why it matters — The stock move coincided with a broader health care sector rise and a company dividend announcement.

UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

Business Wire · 4 Nov 2026positive

UnitedHealth Group’s board authorized a cash dividend of $2.32 per share, payable December 15, 2026, to shareholders of record at the close of business on December 7, 2026.

Why it matters — The authorization sets the dividend amount and key dates for UNH shareholders.

3 High Conviction Stocks + Charitable Giving: Tax Alpha With Raul Shah

Seeking Alpha · 3 Nov 2026neutral

Raul Shah discussed value investing as a way to navigate volatile markets and highlighted UnitedHealth alongside Hims & Hers and ServiceNow. The excerpt provides specific operating details about Hims & Hers, but none about UnitedHealth.

Why it matters — The discussion includes UNH among the stocks highlighted, though the excerpt offers no company-specific rationale or details for UNH.

Top Wide-Moat Stocks to Buy for Steady Long-Term Returns

Zacks Investment Research · 3 Nov 2026positive

Zacks Investment Research names TSM, TXN, UNH and LMT as companies with strong competitive moats that can help fend off rivals and deliver consistent returns amid market shifts.

Why it matters — The item includes UnitedHealth Group among the stocks highlighted for its competitive moat and consistent returns.

FAQ

Frequently asked questions about UNH stock

What is the UNH stock price forecast for 2026-2027?

The 26 Wall Street analysts covering UnitedHealth Group, Inc. have a median 12-month price target of $490, with estimates ranging from $380 to $531. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is UNH stock a buy right now?

Of the 26 analysts covering UnitedHealth Group, Inc., 21 rate it a Buy, 5 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks UnitedHealth Group, Inc. 81 out of 100 across roughly 4,600 US stocks as at 3 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank UNH?

As at 3 Nov 2026, UnitedHealth Group, Inc. ranks 81 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (97 of 100).

Will UNH stock go up?

No one can know that. What the data says: the median 12-month target from 26 analysts implies +19.7% from the last close, and Ticker Nerd's factor model ranks UnitedHealth Group, Inc. 81 out of 100 as at 3 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the UNH stock forecast for 2030?

No analyst covering UnitedHealth Group, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for UNH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $380 to $531 over the next 12 months.

How has UNH stock performed over the past year?

UnitedHealth Group, Inc. returned +27.0% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does UnitedHealth Group, Inc. do?

UnitedHealth Group Inc. is a healthcare and well-being company that operates through two core businesses, UnitedHealthcare and Optum.

What is the latest news on UNH?

The most recent item we track (Seeking Alpha, 4 Nov 2026): "November Dogs Of The Dow: No Buys, Yet 5 Are Worth Watching". The article says no top-ten Dow Dogs currently meet the ideal dividend-to-price ratio, while 21 of 30 are described as safer because robust free cash flow supports payouts. It notes elevated risk and volatility despite analyst targets projecting potential gains through November 2027.

Company

About UnitedHealth Group, Inc.

UnitedHealth Group Inc. is a healthcare and well-being company that operates through two core businesses, UnitedHealthcare and Optum. UnitedHealthcare provides a broad range of health benefit plans and services for employers, individuals, government programs, and public-sector clients, while Optum delivers care delivery, pharmacy care services, health information technology, data analytics, consulting, and managed services. Together, these businesses support patients, care providers, employers, and governments across the health system. UnitedHealth Group plays a central role in health insurance, care coordination, and healthcare services, with a focus on improving access to care, simplifying the consumer experience, and supporting more efficient health system operations. Headquartered in Eden Prairie, Minnesota, and founded in 1974, UnitedHealth Group is one of the most important companies in the healthcare market.

CEO Mr. Stephen J. Hemsley · 390,000 employees · United States · https://www.unitedhealthgroup.com